Cargando…

Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models

SIMPLE SUMMARY: Spread of prostate cancer to other parts of the body is responsible for the majority of deaths. Tumour cell epithelial mesenchymal plasticity (EMP) increases their metastatic potential and facilitates their survival in the blood as circulating tumour cells (CTCs). The aim of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Sara, Blick, Tony, Thompson, Erik W., Williams, Elizabeth D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198708/ https://www.ncbi.nlm.nih.gov/pubmed/34206049 http://dx.doi.org/10.3390/cancers13112750

Ejemplares similares

Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models
por: Hassan, Sara, et al.
Publicado: (2022)

Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer
por: Bhatia, Sugandha, et al.
Publicado: (2019)

TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts
por: Huang, Guangcun, et al.
Publicado: (2016)

Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer—insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system
por: Wafai, Razan, et al.
Publicado: (2020)

Multi-Omics Characterization of the Spontaneous Mesenchymal–Epithelial Transition in the PMC42 Breast Cancer Cell Lines
por: Bhatia, Sugandha, et al.
Publicado: (2019)

Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

Short term ex-vivo expansion of circulating head and neck tumour cells
por: Kulasinghe, Arutha, et al.
Publicado: (2016)

Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2019)

Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition
por: Byrne, N M, et al.
Publicado: (2016)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
por: Agnoletto, Chiara, et al.
Publicado: (2018)

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
por: Lecharpentier, A, et al.
Publicado: (2011)

DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum—Implications for the Choice of Circulating Tumour DNA Methylation Markers
por: Le, Anh Viet-Phuong, et al.
Publicado: (2018)

Differentiated Epithelial- and Mesenchymal-Like Phenotypes in Subcutaneous Mouse Xenografts Using Diffusion Weighted-Magnetic Resonance Imaging
por: Chen, Ya-Wen, et al.
Publicado: (2013)

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.
por: Friedlander, M. L., et al.
Publicado: (1985)

Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin
por: Yang, Faying, et al.
Publicado: (2020)

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
por: Braekeveldt, Noémie, et al.
Publicado: (2015)

Proliferative response of human prostate tumour xenografts to surgical trauma and the transurethral resection of the prostate controversy.
por: Bogden, A. E., et al.
Publicado: (1996)

Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
por: Pearce, David R., et al.
Publicado: (2023)

Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen
por: Bhatia, Sugandha, et al.
Publicado: (2020)

Comparative mutational landscape analysis of patient-derived tumour xenografts
por: Brait, Mariana, et al.
Publicado: (2017)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
por: Gorges, Tobias M, et al.
Publicado: (2012)

Metastatic phenotype in CWR22 prostate cancer xenograft following castration
por: Seedhouse, Steven J., et al.
Publicado: (2015)

Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients
por: Carneiro, Adriana, et al.
Publicado: (2022)

Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial–Mesenchymal Plasticity
por: McInnes, Linda M., et al.
Publicado: (2015)

Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer
por: Liu, Hailong, et al.
Publicado: (2020)

Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case
por: Chai, Shoujie, et al.
Publicado: (2022)

Establishing Prostate Cancer Patient Derived Xenografts: Lessons Learned From Older Studies
por: Russell, Pamela J, et al.
Publicado: (2015)

Stability of the hybrid epithelial/mesenchymal phenotype
por: Jolly, Mohit Kumar, et al.
Publicado: (2016)

Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients
por: Cha, Jiwon, et al.
Publicado: (2023)

Patient-derived tumour xenografts for breast cancer drug discovery
por: Cassidy, John W, et al.
Publicado: (2016)

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
por: Georgopoulou, Dimitra, et al.
Publicado: (2021)

Effects of HMGA2 on the epithelial-mesenchymal transition-related genes in ACHN renal cell carcinoma cells-derived xenografts in nude mice
por: Liu, Ying, et al.
Publicado: (2022)

Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin
por: Hugo, H. J., et al.
Publicado: (2017)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016)

Epithelial to mesenchymal transition and breast cancer
por: Tomaskovic-Crook, Eva, et al.
Publicado: (2009)

A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts
por: Li, Ling, et al.
Publicado: (2022)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer
por: Wu, Fengjie, et al.
Publicado: (2017)

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA
por: Watson, S A, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_iqmd0bk4jghfbrpk0o8urt6jnc